GlassScriptPhysician profile
Todd D Brandt
NPI 1417944604
$281.56
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.61 · 2021: $27.36 · 2022: $89.81 · 2023: $14.66 · 2024: $30.30 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $56.49 | 2020-2025 | Axonics |
| Srs Medical Systems, INC. | $40.25 | 2022 | |
| Abbvie INC. | $30.23 | 2023-2025 | Botox |
| Coloplast Corp | $27.36 | 2021 | |
| Ethicon US, LLC | $19.04 | 2022 | |
| Pfizer INC. | $18.83 | 2025 | |
| Myovant Sciences INC. | $17.12 | 2022 | |
| Progenics Pharmaceuticals, INC. | $15.50 | 2024 | |
| Calyxo, INC. | $14.91 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $14.80 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.63 | 2025 | Lynparza |
| Antares Pharma, INC. | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.